Nixon Peabody Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.1M Sell
32,410
-895
-3% -$363K 1.02% 31
2025
Q1
$16.6M Buy
33,305
+126
+0.4% +$62.7K 1.41% 21
2024
Q4
$17.3M Sell
33,179
-452
-1% -$235K 1.42% 20
2024
Q3
$20.8M Buy
33,631
+103
+0.3% +$63.7K 1.73% 14
2024
Q2
$18.5M Sell
33,528
-10
-0% -$5.53K 1.65% 17
2024
Q1
$19.5M Buy
33,538
+1,996
+6% +$1.16M 1.79% 13
2023
Q4
$16.7M Buy
31,542
+27,402
+662% +$14.5M 1.88% 12
2023
Q3
$2.1M Sell
4,140
-12
-0.3% -$6.07K 1.75% 23
2023
Q2
$2.17M Sell
4,152
-1,181
-22% -$616K 1.76% 16
2023
Q1
$3.07M Buy
5,333
+555
+12% +$320K 2.15% 10
2022
Q4
$2.63M Sell
4,778
-27
-0.6% -$14.9K 2.13% 9
2022
Q3
$2.44M Sell
4,805
-4,049
-46% -$2.05M 2.07% 11
2022
Q2
$4.81M Sell
8,854
-570
-6% -$310K 2.17% 11
2022
Q1
$5.57M Sell
9,424
-583
-6% -$344K 1.92% 16
2021
Q4
$6.68M Buy
10,007
+15
+0.2% +$10K 2.02% 15
2021
Q3
$5.71M Buy
9,992
+51
+0.5% +$29.1K 2.06% 17
2021
Q2
$5.02M Sell
9,941
-439
-4% -$221K 1.93% 22
2021
Q1
$4.74M Sell
10,380
-328
-3% -$150K 1.92% 22
2020
Q4
$4.99M Buy
10,708
+30
+0.3% +$14K 2.1% 17
2020
Q3
$4.72M Sell
10,678
-879
-8% -$388K 2.17% 14
2020
Q2
$4.19M Buy
11,557
+404
+4% +$146K 2.13% 15
2020
Q1
$3.16M Buy
11,153
+11
+0.1% +$3.12K 1.95% 21
2019
Q4
$3.62M Buy
11,142
+5
+0% +$1.62K 1.8% 28
2019
Q3
$3.24M Buy
11,137
+1,353
+14% +$394K 1.73% 31
2019
Q2
$2.87M Buy
9,784
+2,531
+35% +$743K 1.62% 34
2019
Q1
$1.99M Buy
7,253
+1,921
+36% +$526K 1.3% 39
2018
Q4
$1.19M Sell
5,332
-171
-3% -$38.3K 0.94% 42
2018
Q3
$1.34M Buy
5,503
+3
+0.1% +$732 0.92% 43
2018
Q2
$1.14M Buy
5,500
+739
+16% +$153K 0.88% 44
2018
Q1
$983K Sell
4,761
-156
-3% -$32.2K 0.88% 44
2017
Q4
$934K Buy
4,917
+182
+4% +$34.6K 0.8% 45
2017
Q3
$896K Sell
4,735
-195
-4% -$36.9K 0.81% 46
2017
Q2
$860K Sell
4,930
-30
-0.6% -$5.23K 0.8% 47
2017
Q1
$762K Sell
4,960
-115
-2% -$17.7K 0.72% 51
2016
Q4
$716K Buy
5,075
+1,395
+38% +$197K 0.7% 50
2016
Q3
$585K Sell
3,680
-2,083
-36% -$331K 0.57% 56
2016
Q2
$852K Buy
5,763
+240
+4% +$35.5K 0.74% 49
2016
Q1
$782K Buy
5,523
+25
+0.5% +$3.54K 0.7% 52
2015
Q4
$780K Buy
+5,498
New +$780K 0.71% 53